Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia.
- DOI
- 10.1016/j.esmoop.2026.106905
- Published
- 2026 Apr
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.106905,
title = {Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia.},
author = {Rugo HS and Tolaney SM and Cortés J and Marmé F and de Azambuja E and Xu B and Sohn J and Naito Y and Valdez T and Gary D and Zhu J and Lai C and Bardia A},
year = {2026},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2026.106905},
url = {https://doi.org/10.1016/j.esmoop.2026.106905}
}RIS
TY - JOUR TI - Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia. AU - Rugo HS AU - Tolaney SM AU - Cortés J AU - Marmé F AU - de Azambuja E AU - Xu B AU - Sohn J AU - Naito Y AU - Valdez T AU - Gary D AU - Zhu J AU - Lai C AU - Bardia A PY - 2026 JO - ESMO open DO - 10.1016/j.esmoop.2026.106905 UR - https://doi.org/10.1016/j.esmoop.2026.106905 ER -
APA
HS, R., SM, T., J, C., F, M., E, D. A., B, X., J, S., Y, N., T, V., D, G., J, Z., C, L., & A, B. (2026). Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia.. ESMO open. https://doi.org/10.1016/j.esmoop.2026.106905
Source records
- pubmed · retrieved 2026-09-26T19:55:58.401Z